2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with 7-hydroxystaurosporine in 1 studies
Studies (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Trials (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Recent Studies (post-2010) (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Studies (7-hydroxystaurosporine) | Trials (7-hydroxystaurosporine) | Recent Studies (post-2010) (7-hydroxystaurosporine) |
---|---|---|---|---|---|
31 | 0 | 6 | 322 | 20 | 51 |
Protein | Taxonomy | 2'-cyano-2'-deoxyarabinofuranosylcytosine (IC50) | 7-hydroxystaurosporine (IC50) |
---|---|---|---|
Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | 0.0099 | |
3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | 0.0055 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azuma, A; Chubb, S; Guo, Y; Hittelman, W; Huang, P; Jiang, Y; Li, Y; Liu, X; Matsuda, A; Plunkett, W | 1 |
1 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and 7-hydroxystaurosporine
Article | Year |
---|---|
Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.
Topics: Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell Line, Tumor; Checkpoint Kinase 1; Chromosome Aberrations; Cytarabine; DNA Damage; Drug Interactions; G2 Phase; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Mitosis; Protein Kinases; Signal Transduction; Staurosporine | 2005 |